Ikena Oncology, Inc.IKNANASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P46
Within normal range
Average
269.43%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 2024-100.00%
Q4 2023-44.39%
Q3 2023-40.87%
Q2 2023-62.28%
Q1 2023-2.51%
Q4 2022-14.87%
Q3 20221575.92%
Q2 2022-88.71%
Q1 2022-83.26%
Q4 2021439.70%
Q3 20215.55%
Q2 20212.16%
Q1 20215244.62%
Q4 2020-97.70%
Q3 2020-7.94%
Q2 2020-4.77%
Q1 202015.09%
Q4 20190.00%